Monday, November 25, 2013
A series of significant venture
rounds last week pushed the money raised by private biotechs this year across
the $5 billion mark, making it the 10th straight year in which the industry has
crossed the threshold.
This year's money has already
eclipsed the low water mark of the last decade, when only $5.1 billion was
raised in 2010 (see "Making the Mark").